Mark Andrew Wilson, Chief Legal Officer at NEKTAR THERAPEUTICS (NKTR), sold 49,962 shares at $0.89 ($45K) on 2024-12-24, disclosed to the SEC on 2024-12-26.
Open-market sale of $45k NKTR by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.90 | 33,402 | $30K | 67.1% |
| 2 | $0.89 | 16,560 | $15K | 32.9% |
| Total | $0.90 avg | 49,962 | $45K | 100% |
| Filing → |
| NKTR | SELL | 2025-05-21 | $7K | — | Filing → |
| NKTR | SELL | 2025-02-21 | $11K | — | Filing → |
| NKTR | SELL | 2024-11-20 | $6K | — | Filing → |